Research.Patient.info
Plasma Cell Myeloma Refractory research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE1
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
This study is testing a new drug, SAR446523, for people in the UK with a type of blood cancer called myeloma that has come back or is no longer responding to usual treatments. It's looking at how safe the drug is and how well it works.
United States · Australia · Canada - recruitingPHASE1, PHASE2
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
This study looks at new drug combinations with isatuximab and other treatments for a type of blood cancer called multiple myeloma. It aims to find better ways to treat patients whose cancer has come back or hasn't responded to previous treatments.
United States · Australia · France